NEWARK, Del., July 16, 2026 — The global Gel Implants Market is projected to grow from USD 1.4 billion in 2026 to USD 1.9 billion by 2036, registering a 3.3% CAGR during the forecast period. Rising awareness of aesthetic treatments, technological advancements in implant materials, increasing breast reconstruction procedures following mastectomy, and growing disposable incomes are expected...

The Modulated Aspiration Devices Market is expected to witness significant growth as healthcare providers increasingly adopt advanced aspiration technologies to improve clot removal efficiency and patient outcomes in neurovascular and cardiovascular interventions. According to Future Market Insights (FMI), the market is projected to grow from USD 185.0 million in 2026 to USD 430.0 million by...

The Neuro-Restoration Spinal Cord Injury Venture Capital Market is poised for remarkable expansion as global healthcare investors increase funding for neurotechnology, regenerative medicine, and spinal cord injury restoration therapies. According to Future Market Insights (FMI), the market is projected to grow from USD 45.0 million in 2026 to USD 356.7 million by 2036, registering a robust...

The Neuro-Restoration Spinal Cord Injury Venture Capital Market is poised for remarkable expansion as global healthcare investors increase funding for neurotechnology, regenerative medicine, and spinal cord injury restoration therapies. According to Future Market Insights (FMI), the market is projected to grow from USD 45.0 million in 2026 to USD 356.7 million by 2036, registering a robust...

According to the latest analysis by Future Market Insights (FMI), the global Lateral Flow Assays Market is poised for steady growth, driven by increasing demand for rapid diagnostic testing, expanding adoption of point-of-care healthcare solutions, rising prevalence of infectious diseases, and continuous advancements in digital diagnostic technologies. As healthcare systems worldwide emphasize...

The global Small-Molecule Injectable Market, according to Future Market Insights (FMI), is entering a robust growth phase, fueled by increasing hospital pharmaceutical consumption, expanding generic injectable portfolios, and growing demand for critical care medications. The market is projected to grow from USD 162.4 billion in 2026 to USD 322.5 billion by 2036, registering a CAGR of 7.1%...